India

Oppo India is undertaking a major expansion of its after-sales service infrastructure, announcing the launch of 110 new service centers across the country. This move aims to enhance customer experience, improve service turnaround times, and strengthen the brand’s footprint in both urban and semi-urban markets. By broadening its service network, Oppo seeks to address growing consumer demand, ensure faster repairs, and boost overall customer satisfaction in a competitive smartphone market.

India’s rice exporters are set to benefit significantly following the recent reduction of US import tariffs on Indian rice, creating new opportunities for market expansion and revenue growth. The cut has made Indian rice more competitive in the United States, the world’s second-largest rice importer, by lowering landed costs and enhancing profit margins for exporters. Analysts predict this move will bolster shipments of basmati and non-basmati varieties, support rural farmers, and strengthen India’s position in the global rice market.

India’s Unified Payments Interface (UPI) has achieved a record-breaking milestone, with transactions reaching Rs. 230 lakh crore, reinforcing the nation’s rapid shift toward digital payments. The surge reflects growing adoption across urban and rural centers, facilitated by government initiatives, fintech innovations, and increased smartphone penetration. Analysts note that UPI’s interoperability, convenience, and real-time processing have made it the preferred mode for retail, peer-to-peer, and merchant payments.

India’s exports to the United States are expected to see substantial growth in the coming years, according to Finance Minister Nirmala Sitharaman. Speaking at a recent trade and investment forum, she highlighted India’s expanding manufacturing capabilities, strategic trade partnerships, and rising competitiveness in sectors such as pharmaceuticals, IT services, textiles, and engineering goods.

India’s Finance Minister has emphasized the government’s commitment to sustaining a robust 7–8% economic growth trajectory, signaling strategic policy measures to support investment, consumption, and fiscal prudence. The roadmap focuses on infrastructure expansion, digital economy promotion, and sectoral reforms, aiming to enhance productivity and competitiveness. Policymakers are prioritizing fiscal discipline, targeted capital allocation, and investor confidence to ensure growth is inclusive and resilient amid global uncertainties.

Global ratings agency S&P Global has affirmed that India is on track to meet its fiscal deficit target for FY27, reflecting strong macroeconomic fundamentals and prudent fiscal management. The assessment highlights India’s robust revenue collections, controlled expenditure growth, and commitment to structural reforms, which collectively enhance fiscal credibility. Despite challenges such as rising global interest rates and inflationary pressures, S&P notes that India’s sound debt trajectory and proactive policy measures underpin its ability to maintain fiscal discipline.

India’s latest budget has placed health care and biopharmaceutical innovation at the center of its growth strategy, signaling a long-term commitment to research-driven development and public health resilience. Enhanced allocations, targeted incentives, and policy reforms aim to strengthen domestic manufacturing, accelerate innovation, and reduce import dependence in critical segments. The focus extends from drug discovery and biotechnology research to digital health and advanced medical infrastructure.

Indian equity benchmarks tumbled sharply after reports of a proposed hike in the Securities Transaction Tax (STT) unsettled investor sentiment. The Sensex and Nifty witnessed broad-based selling as market participants reassessed trading costs and near-term liquidity conditions. The prospect of higher transaction taxes triggered profit-booking across sectors, with rate-sensitive and high-turnover stocks bearing the brunt. Analysts cautioned that even modest increases in STT can materially affect derivatives volumes and short-term trading strategies.

The Income Tax Act, 2025 is set to come into force on April 1, ushering in a significant overhaul of India’s direct tax framework. The new law is designed to simplify compliance, modernize tax administration, and provide greater clarity to taxpayers. By streamlining provisions and updating language, the Act aims to reduce disputes and improve transparency. Its implementation is expected to have wide-ranging implications for individuals, businesses, and investors, influencing tax planning and compliance practices.

The government is considering a Rs. 10,000 crore investment proposal for the biopharmaceutical sector in the upcoming Union Budget, signaling a strategic push to strengthen India’s life sciences ecosystem. The proposed allocation is aimed at boosting research and development, expanding manufacturing capacity, and reducing import dependence in critical therapies and vaccines. The move aligns with India’s long-term goal of becoming a global biopharma hub while enhancing healthcare security.